Skip to main content

Huh Hoyoung

No open-market purchases or sales filed in the past year.

Current role at each company

Open-market trades in the past year

Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.

Bought
–
0 filings
Sold
–
0 filings
Net
–
Bought minus sold
Companies
0
With open-market trades

Trades

Every Form 4 that lists Huh Hoyoung as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.

AKTX Akari Therapeutics Plc

Director, 10% Owner1 trade

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Dec 18, 2025 (view filing)9:57 PM ETDec 162 daysHuh HoyoungDirector, 10% OwnerPPurchaseAmerican Depositary Shares representing Ordinary Shares+7.42M$0.4041+$1.50M–3.09M afterDerivative4 lots

PKBO Peak Bio, Inc.

Director, 10% Owner6 trades

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Sep 25, 2023 (view filing)Sep 214 daysHuh HoyoungDirector, 10% OwnerPPurchase+45.0K––+0.5%8.38M after
Sep 21, 2023 (view filing)Sep 19-202 daysHuh HoyoungDirector, 10% OwnerPPurchase+80.0K––+1.0%8.34M after2 lots
Sep 19, 2023 (view filing)Sep 154 daysHuh HoyoungDirector, 10% OwnerPPurchase+25.0K––+0.3%8.26M after
Sep 15, 2023 (view filing)Sep 13-142 daysHuh HoyoungDirector, 10% OwnerPPurchase+50.0K––+0.6%8.23M after2 lots
Sep 13, 2023 (view filing)Sep 11-122 daysHuh HoyoungDirector, 10% OwnerPPurchase+47.0K––+0.6%8.18M after2 lots
Sep 12, 2023 (view filing)Aug 29-3114 daysHuh HoyoungDirector, 10% OwnerPPurchase0–$00.0%8.14M afterAmended7 lots